Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06622239
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-11
Brief Title:
Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Double-Blinded Clinical Trial to Evaluate the Effects of Naltrexone in Improving Nonsuicidal Self-injurious Behavior
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NiNsSIB
Brief Summary:
The goal of this clinical trial is to learn if naltrexone works to treat nonsuicidal self-injurious behavior in adolescents and adults
Detailed Description:
Recruiting participants with nonsuicidal self-injurious behavior and randomizing them to the experiment group and the control group at a 11 ratio the test group administers the experiment drug naltrexone along with the general treatment and the control group provides a placebo Clinical evaluation including the frequency of self-injurious behavior is conducted every two weeks The investigator and participants will double-blinded Analyze the relationship between changes in clinical symptoms and socio-demographic characteristics diagnosis clinical characteristics and anticipated to discover predictors of treatment effectiveness
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None